Literature DB >> 23580159

Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

José Fidel Baizabal-Carvallo1, Cecilia Bonnet, Joseph Jankovic.   

Abstract

Movement disorders (MDs), particularly chorea, may be the presenting neurological complication of systemic lupus erythematosus (SLE) and the antiphospholipid syndrome (APS), but the association is not often initially recognized. Current evidence suggests an autoimmune mechanism related to antiphospholipid antibodies in these two conditions, although the antigenic target within the central nervous system has not yet been identified. Based on a comprehensive review of the literature, this article summarizes the current knowledge on MDs in SLE and APS. A high index of suspicion is required to make an early diagnosis and initiate appropriate treatment to provide symptomatic relief and to prevent other systemic complications related to the autoimmune process.

Entities:  

Mesh:

Year:  2013        PMID: 23580159     DOI: 10.1007/s00702-013-1023-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  137 in total

1.  CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

Authors:  E L DUBOIS; D L TUFFANELLI
Journal:  JAMA       Date:  1964-10-12       Impact factor: 56.272

2.  [Systemic lupus erythematosus presenting with a choreo-athetosic syndrome associated with antiphospholipid antibodies].

Authors:  M A Rafai; B El Moutawakil; I Gam; K Hakim; H Fadel; N Kissani; I Slassi
Journal:  Rev Neurol (Paris)       Date:  2005-10       Impact factor: 2.607

3.  Antiphospholipid antibodies bind to rat cerebellar granule cells: the role of N-methyl-D-aspartate receptors.

Authors:  A Riccio; C Andreassi; M L Eboli
Journal:  Neurosci Lett       Date:  1998-11-27       Impact factor: 3.046

4.  Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus.

Authors:  Takahisa Gono; Yasushi Kawaguchi; Hirotaka Kaneko; Katsuji Nishimura; Masanori Hanaoka; Sayuri Kataoka; Yuko Okamoto; Yasuhiro Katsumata; Hisashi Yamanaka
Journal:  Rheumatology (Oxford)       Date:  2011-01-05       Impact factor: 7.580

5.  Tourette's disorder: is there an association with the antiphospholipid syndrome?

Authors:  P Toren; A Toren; A Weizman; T Mozes; S Eldar; A Magor; M Mandel; G Rechavi; A Many; R Mester
Journal:  Biol Psychiatry       Date:  1994-04-01       Impact factor: 13.382

Review 6.  Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

Authors:  Pier Luigi Meroni; M Orietta Borghi; Elena Raschi; Francesco Tedesco
Journal:  Nat Rev Rheumatol       Date:  2011-05-10       Impact factor: 20.543

7.  Intracortical inhibition of the motor cortex is normal in chorea.

Authors:  R Hanajima; Y Ugawa; Y Terao; T Furubayashi; K Machii; Y Shiio; H Enomoto; H Uesugi; H Mochizuki; I Kanazawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

8.  Subacute pancerebellar syndrome associated with systemic lupus erythematosus.

Authors:  M U Manto; P Rondeaux; J Jacquy; J G Hildebrand
Journal:  Clin Neurol Neurosurg       Date:  1996-05       Impact factor: 1.876

9.  Hemichorea in systemic lupus erythematosus: significance of MRI findings.

Authors:  F al Jishi; M Z al Kawi; K el Ramahi; S Omer
Journal:  Lupus       Date:  1995-08       Impact factor: 2.911

10.  Lupus erythematosus and Miller-Fisher syndrome.

Authors:  R Bingisser; R Speich; A Fontana; J Gmür; B Vogel; T Landis
Journal:  Arch Neurol       Date:  1994-08
View more
  22 in total

1.  Reversible chorea and parkinsonism in a patient with systemic lupus erythematosus.

Authors:  Min Kim; Sun Min Lee; Jung Han Yoon
Journal:  Neurol Sci       Date:  2015-12-21       Impact factor: 3.307

2.  Diurnal Salivary Cortisol and Regression Status in MECP2 Duplication Syndrome.

Authors:  Sarika U Peters; Breanne J Byiers; Frank J Symons
Journal:  J Child Neurol       Date:  2015-05-21       Impact factor: 1.987

3.  Movement disorders in systemic lupus erythematosus and antiphospholipid syndrome--a video presentation.

Authors:  Kanterpersad Ramcharan; Kamille Abdool; Navindra Persad; Haramnauth Dyaanand
Journal:  BMJ Case Rep       Date:  2015-05-07

4.  Acute parkinsonism as first manifestation of systemic lupus erythematosus unmasked by CMV infection.

Authors:  Marco Marino; Francesca Morgante; Federica Montagnese; Antonio Toscano; Olimpia Musumeci
Journal:  Neurol Sci       Date:  2014-06-01       Impact factor: 3.307

5.  Jaw Dystonia and Reversible Basal Ganglia Changes as an Initial Presentation of Systemic Lupus Erythematosus.

Authors:  Meghan Romba; Yujie Wang; Shu-Ching Hu; Sandeep Khot
Journal:  Neurohospitalist       Date:  2017-03-10

6.  Reversible Acute Parkinsonism and Unusual Neuroimaging Findings in Systemic Lupus Erythematosus.

Authors:  Marianna P Moraes de Moraes; Rubens P A Salomão; André C Felício; Fabiano F Abrantes; Orlando G P Barsottini; José L Pedroso
Journal:  Mov Disord Clin Pract       Date:  2020-04-07

Review 7.  Current treatment of antiphospholipid syndrome: lights and shadows.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Nat Rev Rheumatol       Date:  2015-06-30       Impact factor: 20.543

Review 8.  Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  J Neural Transm (Vienna)       Date:  2017-07-08       Impact factor: 3.575

Review 9.  Skin Conditions and Movement Disorders: Hiding in Plain Sight.

Authors:  Kristina Kulcsarova; Janette Baloghova; Jan Necpal; Matej Skorvanek
Journal:  Mov Disord Clin Pract       Date:  2022-03-24

Review 10.  Movement disorders and neuropathies: overlaps and mimics in clinical practice.

Authors:  Francesco Gentile; Alessandro Bertini; Alberto Priori; Tommaso Bocci
Journal:  J Neurol       Date:  2022-06-03       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.